BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26512980)

  • 21. Brevinin-2-related peptide and its [D4K] analogue stimulate insulin release in vitro and improve glucose tolerance in mice fed a high fat diet.
    Abdel-Wahab YH; Patterson S; Flatt PR; Conlon JM
    Horm Metab Res; 2010 Aug; 42(9):652-6. PubMed ID: 20496306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Taurine supplementation prevents morpho-physiological alterations in high-fat diet mice pancreatic β-cells.
    Ribeiro RA; Santos-Silva JC; Vettorazzi JF; Cotrim BB; Mobiolli DD; Boschero AC; Carneiro EM
    Amino Acids; 2012 Oct; 43(4):1791-801. PubMed ID: 22418865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice.
    Mohan S; McCloskey AG; McKillop AM; Flatt PR; Irwin N; Moffett RC
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129811. PubMed ID: 33309687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study.
    Musale V; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YH
    Peptides; 2021 Feb; 136():170472. PubMed ID: 33338546
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptides from frog skin with potential for development into agents for Type 2 diabetes therapy.
    Conlon JM; Mechkarska M; Abdel-Wahab YH; Flatt PR
    Peptides; 2018 Feb; 100():275-281. PubMed ID: 28887047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beneficial effects of tigerinin-1R on glucose homeostasis and beta cell function in mice with diet-induced obesity-diabetes.
    Ojo OO; Srinivasan DK; Owolabi BO; Flatt PR; Abdel-Wahab YH
    Biochimie; 2015 Feb; 109():18-26. PubMed ID: 25483926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration of high fat diet-induced glucose intolerance by blockade of Smad4 in pancreatic beta-cells.
    Li HY; Oh YS; Lee YJ; Lee EK; Jung HS; Jun HS
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):221-6. PubMed ID: 25502579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tigerinin-1R: a potent, non-toxic insulin-releasing peptide isolated from the skin of the Asian frog, Hoplobatrachus rugulosus.
    Ojo OO; Abdel-Wahab YH; Flatt PR; Mechkarska M; Conlon JM
    Diabetes Obes Metab; 2011 Dec; 13(12):1114-22. PubMed ID: 21736689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Magainin-AM2 improves glucose homeostasis and beta cell function in high-fat fed mice.
    Ojo OO; Srinivasan DK; Owolabi BO; Conlon JM; Flatt PR; Abdel-Wahab YH
    Biochim Biophys Acta; 2015 Jan; 1850(1):80-7. PubMed ID: 25459513
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the potential of temporin peptides from the frog Rana temporaria (Ranidae) as anti-diabetic agents.
    Musale V; Casciaro B; Mangoni ML; Abdel-Wahab YHA; Flatt PR; Conlon JM
    J Pept Sci; 2018 Feb; 24(2):. PubMed ID: 29349894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (Val(8))GLP-1-Glu-PAL: a GLP-1 agonist that improves hippocampal neurogenesis, glucose homeostasis, and β-cell function in high-fat-fed mice.
    Lennox R; Porter DW; Flatt PR; Gault VA
    ChemMedChem; 2013 Apr; 8(4):595-602. PubMed ID: 23138973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, suppresses high fat diet-induced obesity and glucose intolerance in Sprague-Dawley rats.
    Hata T; Mera Y; Tadaki H; Kuroki Y; Kawai T; Ohta T; Kakutani M
    Diabetes Obes Metab; 2011 May; 13(5):446-54. PubMed ID: 21255216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic Islet APJ Deletion Reduces Islet Density and Glucose Tolerance in Mice.
    Han S; Englander EW; Gomez GA; Rastellini C; Quertermous T; Kundu RK; Greeley GH
    Endocrinology; 2015 Jul; 156(7):2451-60. PubMed ID: 25965959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.
    Green BD; Lavery KS; Irwin N; O'harte FP; Harriott P; Greer B; Bailey CJ; Flatt PR
    J Pharmacol Exp Ther; 2006 Aug; 318(2):914-21. PubMed ID: 16648370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat-Fed Mice.
    Irwin N; Pathak V; Flatt PR
    Diabetes; 2015 Aug; 64(8):2996-3009. PubMed ID: 25883113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potent, non-toxic insulin-releasing peptide isolated from an extract of the skin of the Asian frog, Hylarana guntheri (Anura:Ranidae).
    Conlon JM; Power GJ; Abdel-Wahab YH; Flatt PR; Jiansheng H; Coquet L; Leprince J; Jouenne T; Vaudry H
    Regul Pept; 2008 Nov; 151(1-3):153-9. PubMed ID: 18501981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting inhibition of CCR5 on improving obesity-associated insulin resistance and impairment of pancreatic insulin secretion in high fat-fed rodent models.
    Chan PC; Liao MT; Lu CH; Tian YF; Hsieh PS
    Eur J Pharmacol; 2021 Jan; 891():173703. PubMed ID: 33159935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel chemically modified analogue of xenin-25 exhibits improved glucose-lowering and insulin-releasing properties.
    Parthsarathy V; Irwin N; Hasib A; Martin CM; McClean S; Bhat VK; Ng MT; Flatt PR; Gault VA
    Biochim Biophys Acta; 2016 Apr; 1860(4):757-64. PubMed ID: 26802310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the insulin-releasing and glucose-lowering effects of GPR120 activation in pancreatic β-cells.
    Moran BM; Abdel-Wahab YH; Flatt PR; McKillop AM
    Diabetes Obes Metab; 2014 Nov; 16(11):1128-39. PubMed ID: 24919766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antagonism of gastric inhibitory polypeptide (GIP) by palmitoylation of GIP analogues with N- and C-terminal modifications improves obesity and metabolic control in high fat fed mice.
    Pathak V; Gault VA; Flatt PR; Irwin N
    Mol Cell Endocrinol; 2015 Feb; 401():120-9. PubMed ID: 25449420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.